All results reported are continuing operations, unless otherwise notedQuarterly revenue of $67.3 million, representing an increase of 9% ...
Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, AscensiaPatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback